Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$22.4M
+35.7% from 2023
Prescriptions
2,970
$7,558.68 per claim
Patients
1,135
690 prescribers
Total spending, 2024
$22.5M
$19,779.67 per patient
Medicare prescription drug plans paid $22.4M for Ruxience in 2024, for 2,970 prescriptions and refills to 1,135 patients (up 35.7% from 2023). The average cost per claim was $7,558.68.
Florida had the highest Medicare cost for Ruxience in 2024: $4.5M for 575 claims, followed by California ($4.4M).
Sejal N Vaidya, nurse practitioner in Silver Spring, MD, had the highest Medicare cost for Ruxience in 2024: 86 claims costing $469K.
Ruxience is made by Pfizer Inc. (PFE), listed in the Medicare spending data as Pfizer US Pharm.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Sejal N Vaidya Silver Spring, MD | Nurse Practitioner | 86 | 33 | $469K |
| Elvin R Garcia McAllen, TX | Rheumatology | 31 | 17 | $418K |
| Hayman S Salib Easton, PA |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 239 | 1,074 | 364 | $7.5M |
| 2023 | 487 | 2,204 | 791 | $16.5M |
| 2024 | 690 | 2,970 | 1,135 | $22.4M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 11 |
| Under 11 |
| $310K |
| Norman B Gaylis Aventura, FL | Rheumatology | 23 | 16 | $294K |
| Ronald Yglesias Aventura, FL | Rheumatology | 16 | 11 | $222K |
| Pratibha K Desai Saint Petersburg, FL | Hematology-Oncology | 35 | Under 11 | $214K |
| Rohit Kapoor Live Oak, TX | Hematology-Oncology | 26 | Under 11 | $202K |
| Megha Shah Flemington, NJ | Hematology-Oncology | 15 | Under 11 | $181K |
| Michael H Nguyen Torrance, CA | Hematology-Oncology | 30 | Under 11 | $181K |
| William R Mitchell Huntersville, NC | Hematology-Oncology | 19 | Under 11 | $177K |
| Amir A Rasheed Baytown, TX | Hematology-Oncology | 31 | Under 11 | $175K |
| Alec S Goldenberg New York, NY | Hematology-Oncology | 23 | Under 11 | $169K |
| Myron E Bednar Flemington, NJ | Hematology | 22 | Under 11 | $159K |
| Eugenio G Galindo McAllen, TX | Hematology-Oncology | 14 | Under 11 | $159K |
| Krisztina I Larson Burbank, CA | Hematology-Oncology | 30 | Under 11 | $148K |
| Laxmi S Iyer Riverside, CA | Hematology-Oncology | 27 | Under 11 | $143K |
| Anas Raowas Fountain Valley, CA | Hematology-Oncology | 15 | Under 11 | $141K |
| Zili He X Flushing, NY | Hematology-Oncology | 32 | Under 11 | $139K |
| Manish Dhawan Minden, LA | Hematology-Oncology | 15 | Under 11 | $136K |
| Jasen C CHI Little Rock, AR | Rheumatology | 16 | Under 11 | $130K |
| Johana F Duque Lauderdale Lakes, FL | Physician Assistant | 11 | Under 11 | $129K |
| Brian S Choi Riverside, CA | Hematology-Oncology | 34 | Under 11 | $129K |
| Naiara Alvarez Harlingen, TX | Rheumatology | 11 | Under 11 | $127K |
| Elizabeth J Delgiacco Christiansted, VI | Medical Oncology | 12 | Under 11 | $126K |
| Howard S Yeh Beverly Hills, CA | Medical Oncology | 21 | Under 11 | $122K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Pfizer US Pharm PFE | 2,972 | $22.5M |